Sign in
4

Changes in Ownership

Climb Bio, Inc. Filed Acc 0000950170-24-139052

CHIEF ACCOUNTING OFFICER sold 1,235 shares at $2.02 ($2,495)

  • CHIEF ACCOUNTING OFFICER acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pimblett Emily CHIEF ACCOUNTING OFFICER 2024-12-18 Option exercise 10b5-1 +5,000 12,564 D: show line 1 in the form
Pimblett Emily CHIEF ACCOUNTING OFFICER 2024-12-19 Sale 10b5-1 −1,235 $2.02 $2,495 11,329 D: show line 2 in the form
Open-market sales · 1,235 sh · avg $2.02 · $2,495

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Pimblett Emily CHIEF ACCOUNTING OFFICER 2024-12-18 Option exercise · Restricted Stock Units 10b5-1 −5,000 25,000 D: show line 3 in the form
Loading xslF345X05/ownership.xml…